Magneto--Acoustic Energetics Study of the Seismically Active Flare of 15 February 2011

Multi--wavelength studies of energetic solar flares with seismic emissions have revealed interesting common features between them. We studied the first GOES X--class flare of the 24th solar cycle, as detected by the Solar Dynamics Observatory (SDO). For context, seismic activity from this flare (SOL2011-02-15T01:55-X2.2, in NOAA AR 11158) has been reported in the literature (Kosovichev, 2011; Zharkov et al., 2011). Based on Dopplergram data from the Helioseismic and Magnetic Imager (HMI), we applied standard methods of local helioseismology in order to identify the seismic sources in this event. RHESSI hard X-ray data are used to check the correlation between the location of the seismic sources and the particle precipitation sites in during the flare. Using HMI magnetogram data, the temporal profile of fluctuations in the photospheric line-of-sight magnetic field is used to estimate the magnetic field change in the region where the seismic signal was observed. This leads to an estimate of the work done by the Lorentz-force transient on the photosphere of the source region. In this instance this is found to be a significant fraction of the acoustic energy in the attendant seismic emission, suggesting that Lorentz forces can contribute significantly to the generation of sunquakes. However, there are regions in which the signature of the Lorentz-force is much stronger, but from which no significant acoustic emission emanates.Comment: Submitted to Solar Physic

A statistical correlation of sunquakes based on their seismic and white-light emission

Several mechanisms have been proposed to explain the transient seismic emission, i.e. “sunquakes,” from some solar flares. Some theories associate high-energy electrons and/or white-light emission with sunquakes. High-energy charged particles and their subsequent heating of the photosphere and/or chromosphere could induce acoustic waves in the solar interior. We carried out a correlative study of solar flares with emission in hard X-rays, enhanced continuum emission at 6173 Å, and transient seismic emission. We selected those flares observed by the Reuven Ramaty High Energy Solar Spectroscopic Imager (RHESSI) with a considerable flux above 50 keV between 1 January 2010 and 26 June 2014. We then used data from the Helioseismic and Magnetic Imager onboard the Solar Dynamic Observatory to search for excess visible-continuum emission and new sunquakes not previously reported. We found a total of 18 sunquakes out of 75 flares investigated. All of the sunquakes were associated with an enhancement of the visible continuum during the flare. Finally, we calculated a coefficient of correlation for a set of dichotomic variables related to these observations. We found a strong correlation between two of the standard helioseismic detection techniques, and between sunquakes and visible-continuum enhancements. We discuss the phenomenological connectivity between these physical quantities and the observational difficulties of detecting seismic signals and excess continuum radiation

The need for focused, hard X-ray investigations of the Sun

Understanding the nature of energetic particles in the solar atmosphere is one of the most important outstanding problems in heliophysics. Flare-accelerated particles compose a huge fraction of the flare energy budget; they have large influences on how events develop; they are an important source of high-energy particles found in the heliosphere; and they are the single most important corollary to other areas of high-energy astrophysics. Despite the importance of this area of study, this topic has in the past decade received only a small fraction of the resources necessary for a full investigation. For example, NASA has selected no new Explorer-class instrument in the past two decades that is capable of examining this topic. The advances that are currently being made in understanding flare-accelerated electrons are largely undertaken with data from EOVSA (NSF), STIX (ESA), and NuSTAR (NASA Astrophysics). This is despite the inclusion in the previous Heliophysics decadal survey of the FOXSI concept as part of the SEE2020 mission, and also despite NASA's having invested heavily in readying the technology for such an instrument via four flights of the FOXSI sounding rocket experiment. Due to that investment, the instrumentation stands ready to implement a hard X-ray mission to investigate flare-accelerated electrons. This white paper describes the scientific motivation for why this venture should be undertaken soon.Comment: White paper submitted to the Decadal Survey for Solar and Space Physics (Heliophysics) 2024-2033; 15 pages, 5 figure

The Gene Ontology knowledgebase in 2023

The Gene Ontology (GO) knowledgebase (http://geneontology.org) is a comprehensive resource concerning the functions of genes and gene products (proteins and noncoding RNAs). GO annotations cover genes from organisms across the tree of life as well as viruses, though most gene function knowledge currently derives from experiments carried out in a relatively small number of model organisms. Here, we provide an updated overview of the GO knowledgebase, as well as the efforts of the broad, international consortium of scientists that develops, maintains, and updates the GO knowledgebase. The GO knowledgebase consists of three components: (1) the GO-a computational knowledge structure describing the functional characteristics of genes; (2) GO annotations-evidence-supported statements asserting that a specific gene product has a particular functional characteristic; and (3) GO Causal Activity Models (GO-CAMs)-mechanistic models of molecular "pathways" (GO biological processes) created by linking multiple GO annotations using defined relations. Each of these components is continually expanded, revised, and updated in response to newly published discoveries and receives extensive QA checks, reviews, and user feedback. For each of these components, we provide a description of the current contents, recent developments to keep the knowledgebase up to date with new discoveries, and guidance on how users can best make use of the data that we provide. We conclude with future directions for the project

Atypical pathogens in hospitalized patients with community-acquired pneumonia: A worldwide perspective

Background: Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods: A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Results: Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Conclusions: Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation

Euclid preparation: XVI. Exploring the ultra-low surface brightness Universe with Euclid /VIS

Context. While Euclid is an ESA mission specifically designed to investigate the nature of dark energy and dark matter, the planned unprecedented combination of survey area (∼15â 000 deg2), spatial resolution, low sky-background, and depth also make Euclid an excellent space observatory for the study of the low surface brightness Universe. Scientific exploitation of the extended low surface brightness structures requires dedicated calibration procedures that are yet to be tested. Aims. We investigate the capabilities of Euclid to detect extended low surface brightness structure by identifying and quantifying sky-background sources and stray-light contamination. We test the feasibility of generating sky flat-fields to reduce large-scale residual gradients in order to reveal the extended emission of galaxies observed in the Euclid survey. Methods. We simulated a realistic set of Euclid/VIS observations, taking into account both instrumental and astronomical sources of contamination, including cosmic rays, stray-light, zodiacal light, interstellar medium, and the cosmic infrared background, while simulating the effects of background sources in the field of view. Results. We demonstrate that a combination of calibration lamps, sky flats, and self-calibration would enable recovery of emission at a limiting surface brightness magnitude of μlim = 29.5-0.27+0.08 mag arcsec-2 (3σ, 10â ×â 10 arcsec2) in the Wide Survey, and it would reach regions deeper by 2 mag in the Deep Surveys. Conclusions.Euclid/VIS has the potential to be an excellent low surface brightness observatory. Covering the gap between pixel-To-pixel calibration lamp flats and self-calibration observations for large scales, the application of sky flat-fielding will enhance the sensitivity of the VIS detector at scales larger than 1″, up to the size of the field of view, enabling Euclid to detect extended surface brightness structures below μlimâ =â 31 mag arcsec-2 and beyond

Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study

This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired pneumonia (CAP) and to assess concordance with the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) and 2011 European Respiratory Society (ERS) CAP guidelines. This was a cohort study based on the Global Initiative for Methicillin-resistant Staphylococcus aureus Pneumonia (GLIMP) database, which contains point-prevalence data on adults hospitalised with CAP across 54 countries during 2015. In total, 3702 patients were included. Testing was performed in 3217 patients, and included blood culture (71.1%), sputum culture (61.8%), Legionella urinary antigen test (30.1%), pneumococcal urinary antigen test (30.0%), viral testing (14.9%), acute-phase serology (8.8%), bronchoalveolar lavage culture (8.4%) and pleural fluid culture (3.2%). A pathogen was detected in 1173 (36.5%) patients. Testing attitudes varied significantly according to geography and disease severity. Testing was concordant with IDSA/ATS and ERS guidelines in 16.7% and 23.9% of patients, respectively. IDSA/ATS concordance was higher in Europe than in North America (21.5% versus 9.8%; p<0.01), while ERS concordance was higher in North America than in Europe (33.5% versus 19.5%; p<0.01). Testing practices of adults hospitalised with CAP varied significantly by geography and disease severity. There was a wide discordance between real-life testing practices and IDSA/ATS/ERS guideline recommendations

Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

Background. The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. Methods. We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. Results. At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non\u2013community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). Conclusions. Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses